-
Portrait | 2023.04.14
Sarah Bonnet, tickologist and educator
Sarah Bonnet is a "tickologist" – she specializes in the study of ticks. More broadly, she is a veterinarian entomologist and medical, a professor and scientist with a passion for field work. Her research is focused on the little-known field of ticks and their many species. She is an enthusiastic educator who loves sharing her expertise and plans for future research. The upheavals we are...
-
Document de presse | 2023.10.19
Genes fuelling antibiotic resistance in Yemen cholera outbreak uncovered
An international collaborative research effort involving scientists from the Wellcome Sanger Institute, the University of Toronto, the Institut Pasteur and Sana'a University has revealed the source of antibiotic resistance that emerged in bacteria driving the cholera outbreak that is currently affecting Yemen. The results of their research, published on September 28, 2023 in the journal Nature...
-
News | 2024.03.25
Tackling flaviviruses and preparing the European Union for emerging threats
The genus flavivirus includes several human pathogens, such as Zika, dengue, West Nile virus (WNV) and yellow fever virus, which persist as major threats to global public health. Yellow4FLAVI, coordinated by Giovanna Barba-Spaeth, Institut Pasteur, comprises 13 partner institutions and is supported by the European Union with with € 8 million. The aim is to use the 17D yellow fever vaccine as...
-
Document de presse | 2024.03.28
Inauguration in Brazil of the Institut Pasteur de São Paulo, member of the Pasteur Network
On March 27, 2024, the Institut Pasteur de São Paulo was inaugurated by French President, Emmanuel Macron. As a member of the Pasteur Network, this institute, founded by the Institut Pasteur and the University of São Paulo, conducts international-level research in the field of health biology to further understanding of diseases and their impact on human health, especially in the context of...
-
News | 2023.09.05
HIV-AIDS: broadly neutralizing antibodies, stars of the lab
Highly promising, broadly neutralizing antibodies can react with the vast majority of HIV particles to cause their destruction by the body. However, the latter would have to be able to produce equally effective antibodies...
-
Portrait | 2023.02.10
Caroline Demangel – an ambitious and enterprising scientist
Finding her path, making meaningful choices and daring to take the initiative – these are the principles that have guided Caroline Demangel through her career. In the demanding and competitive field of science, she has trusted her aspirations and risen to new challenges. In 2021, the scientist and her team revealed a new therapeutic target for bone marrow cancer.
-
Fiche maladie | 2019.09.05
Hearing loss
Hearing loss is a decrease in auditory acuity. It is the most common sensory deficit in humans and can occur at any age, and at various levels of severity. Initially a genetic approach was used to identify the genes responsible for early-onset hearing loss in humans. Studies of these genes then revealed the molecular mechanisms involved in the formation, differentiation and functioning of the...
-
Article | 2017.05.11
My PhD at the Institut Pasteur
The Institut Pasteur welcomes PhD students in close partnership with Masters’ programs and Doctoral schools from the Grand Métropole Paris area (Université Paris Cité, Sorbonne Université, Université Paris-Saclay, Université Paris Sciences et Lettres) and renowned international universities. The Institut Pasteur is committed to high standards of academic, scientific and innovation training, as...
-
Document de presse | 2015.10.28
The Institut Pasteur and Chan Soon-Shiong Institute for Molecular Medicine Partner to Form Global Genomics Center
Paris, France and Los Angeles, CaliforniaThe Chan Soon-Shiong Institute for Molecular Medicine (CSSIOMM) and the Institut Pasteur today announced a partnership to establish The Pasteur Global Health Genomics Center (PGHGC). The aim of the PGHGC is to advance genomic research utilizing next-generation patient information systems needed to support the acquisition and usage of high-quality...
-
Article | 2020.03.27
Coronavirus (Covid-19) research projects
VACCINE CANDIDATES1. Development of an animal model and accelerated development of a DNA vaccine candidate(SCARD SARS-CoV-2 project)Aims:To develop a mouse model of SARS-CoV-2 infection.This will not only enable us to evaluate the efficacy of the vaccine; it will also facilitate in vivo research on SARS-CoV-2. To evaluate the immunogenicity (ability to induce a specific immune reaction) and...